Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia

NCT02100839 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Hyperlipoproteinemia Type II

Interventions

DRUG: AEM-28
DRUG: Normal Saline

Sponsor

LipimetiX Development, LLC